The fate of human Langerhans cells in hematopoietic stem cell transplantation (Q36227929)

12 August 2017

The fate of human Langerhans cells in hematopoietic stem cell transplantation (English)

1 reference

stem cell transplantation

12 August 2017

1 reference

Matthew P Collin

1

1 reference

12 August 2017

Derek N J Hart

2

1 reference

12 August 2017

Graham H Jackson

3

1 reference

12 August 2017

Gordon Cook

4

1 reference

12 August 2017

James Cavet

5

1 reference

12 August 2017

Stephen Mackinnon

6

1 reference

12 August 2017

Peter G Middleton

7

1 reference

12 August 2017

Anne M Dickinson

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

3 January 2006

1 reference

Journal of Experimental Medicine

12 August 2017

1 reference

12 August 2017

203

1 reference

12 August 2017

27-33

1 reference

12 August 2017

1

1 reference

Ontogeny of Lagerhans cells and graft versus host disease

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

Antigen presentation in graft-vs-host disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

The Pathophysiology of Acute Graft-versus-Host Disease

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

Langerhans cells renew in the skin throughout life under steady-state conditions

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

Morphological and immunohistological changes in the skin in allogeneic bone marrow recipients

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

Mononuclear cell subpopulations in the skin defined by monoclonal antibodies after HLA-identical sibling marrow transplantation

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2118090

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

29 June 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20051787

Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20051787

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20051787

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1084%2FJEM.20051787

Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients

21 January 2018

1 reference

12 December 2020

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

12 December 2020

Donor APCs are required for maximal GVHD but not for GVL

1 reference

12 December 2020

The origin of Langerhans cells

1 reference

12 December 2020

Study of Langerhans cells after allogeneic bone marrow transplantation

1 reference

12 December 2020

Cytogenetic identification of allogeneic epidermal Langerhans cells in a bone-marrow-graft recipient

1 reference

12 December 2020

Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans

1 reference

12 December 2020

Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease

1 reference

12 December 2020

Further evidence for the self-reproducing capacity of Langerhans cells in human skin

1 reference

12 December 2020

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

1 reference

12 December 2020

Monitoring human blood dendritic cell numbers in normal individuals and in stem cell transplantation

1 reference

12 December 2020

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

12 December 2020

Turnover of epidermal Langerhans' cells

1 reference

12 December 2020

Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ

1 reference

12 December 2020

In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: implications for the control of Graft-versus-host disease

1 reference

12 December 2020

Campath-1G causes rapid depletion of circulating host dendritic cells (DCs) before allogeneic transplantation but does not delay donor DC reconstitution

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.20051787

1 reference

12 August 2017

1 reference

12 August 2017

1 reference